Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$9.54
+0.7%
$10.56
$9.15
$16.91
$17.26B0.32299,552 shs500,591 shs
CSL Limited stock logo
CSLLY
CSL
$90.16
+0.1%
$92.04
$71.51
$105.11
$87.14B0.7335,425 shs30,378 shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$890.68
-1.7%
$949.30
$684.80
$998.33
$99.50B0.11426,131 shs574,971 shs
Shiseido Company, Limited stock logo
SSDOY
Shiseido
$27.08
-0.9%
$27.35
$25.44
$51.07
$10.92B0.3775,295 shs59,244 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
+0.85%+0.63%-13.83%-16.52%-35.78%
CSL Limited stock logo
CSLLY
CSL
+0.07%+3.73%-2.33%-6.76%-10.23%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
-1.75%-0.37%-7.56%-5.25%+14.48%
Shiseido Company, Limited stock logo
SSDOY
Shiseido
-0.91%+1.42%+2.15%-1.67%-46.16%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
CSL Limited stock logo
CSLLY
CSL
0.9914 of 5 stars
0.05.01.70.01.00.01.3
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
3.989 of 5 stars
2.44.00.02.32.72.51.9
Shiseido Company, Limited stock logo
SSDOY
Shiseido
1.5369 of 5 stars
0.03.02.50.01.00.02.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
2.00
HoldN/AN/A
CSL Limited stock logo
CSLLY
CSL
N/AN/AN/AN/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.70
Moderate Buy$977.779.78% Upside
Shiseido Company, Limited stock logo
SSDOY
Shiseido
N/AN/AN/AN/A

Current Analyst Ratings

Latest CSLLY, REGN, SSDOY, and ALPMY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1,020.00 ➝ $1,030.00
4/17/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1,090.00 ➝ $1,099.00
4/15/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$925.00
4/12/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$710.00 ➝ $720.00
4/9/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$1,189.00
4/3/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$1,135.00
3/26/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$1,135.00
3/13/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$1,104.00 ➝ $1,115.00
3/12/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$1,125.00
2/27/2024
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$1,096.00 ➝ $1,184.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$11.24B1.54$1.36 per share6.99$6.27 per share1.52
CSL Limited stock logo
CSLLY
CSL
$13.31B6.55$3.12 per share28.93$18.48 per share4.88
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$13.12B7.45$42.51 per share20.95$236.63 per share3.76
Shiseido Company, Limited stock logo
SSDOY
Shiseido
$6.94B1.56$2.07 per share13.06$11.88 per share2.28

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$742MN/A24.3321.681.520.08%6.39%3.29%N/A
CSL Limited stock logo
CSLLY
CSL
$2.19BN/A0.0025.11N/AN/AN/AN/AN/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$3.95B$34.7525.6322.072.6030.14%17.61%13.76%5/2/2024 (Confirmed)
Shiseido Company, Limited stock logo
SSDOY
Shiseido
$155.11M$0.3969.4419.62N/A2.26%3.42%1.70%N/A

Latest CSLLY, REGN, SSDOY, and ALPMY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$8.07N/A-$8.07N/AN/AN/A  
2/9/2024Q4 2023
Shiseido Company, Limited stock logo
SSDOY
Shiseido
N/A$0.02+$0.02$0.02N/A$1.70 billion
2/5/2024Q3 2024
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
N/A$0.12+$0.12$0.17N/A$2.86 billion
2/2/202412/31/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$10.73$11.86+$1.13$10.17$3.29 billion$3.43 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$0.343.56%N/AN/AN/A
CSL Limited stock logo
CSLLY
CSL
$1.091.21%N/AN/AN/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
N/AN/AN/AN/AN/A
Shiseido Company, Limited stock logo
SSDOY
Shiseido
$0.291.07%N/A74.36%N/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
0.31
0.91
0.71
CSL Limited stock logo
CSLLY
CSL
N/AN/AN/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.10
5.69
4.94
Shiseido Company, Limited stock logo
SSDOY
Shiseido
0.32
1.29
0.88

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
N/A
CSL Limited stock logo
CSLLY
CSL
0.03%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
83.31%
Shiseido Company, Limited stock logo
SSDOY
Shiseido
0.02%

Insider Ownership

CompanyInsider Ownership
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
N/A
CSL Limited stock logo
CSLLY
CSL
N/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8.83%
Shiseido Company, Limited stock logo
SSDOY
Shiseido
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
14,4841.81 billionN/ANot Optionable
CSL Limited stock logo
CSLLY
CSL
32,000966.51 millionN/ANot Optionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
13,450109.76 million100.07 millionOptionable
Shiseido Company, Limited stock logo
SSDOY
Shiseido
33,414399.65 millionN/ANot Optionable

CSLLY, REGN, SSDOY, and ALPMY Headlines

SourceHeadline
Beauty Insider: Free Ice Baths This Friday; Hairstylist Loses Kit To Theft; Mind-Bending Makeup For ShiseidoBeauty Insider: Free Ice Baths This Friday; Hairstylist Loses Kit To Theft; Mind-Bending Makeup For Shiseido
nzherald.co.nz - April 19 at 1:56 AM
Yamamay and Shiseido back Project M.A.R.E. for Mediterranean conservationYamamay and Shiseido back Project M.A.R.E. for Mediterranean conservation
fashionunited.in - April 11 at 1:25 PM
Shiseido Company, Limited (OTCMKTS:SSDOY) Short Interest UpdateShiseido Company, Limited (OTCMKTS:SSDOY) Short Interest Update
marketbeat.com - April 10 at 7:30 PM
BellRing Brands gains amid new long idea at HedgeyeBellRing Brands gains amid new long idea at Hedgeye
msn.com - April 1 at 4:48 PM
Short Interest in Shiseido Company, Limited (OTCMKTS:SSDOY) Drops By 58.2%Short Interest in Shiseido Company, Limited (OTCMKTS:SSDOY) Drops By 58.2%
marketbeat.com - March 28 at 11:49 AM
Shiseido Ultimune Power Infusing Concentrate III review: My skin felt hydrated, bouncy and not tiredShiseido Ultimune Power Infusing Concentrate III review: 'My skin felt hydrated, bouncy and not tired'
sg.style.yahoo.com - March 27 at 12:47 AM
Best hair mask for dry locks: Shiseido FINO Premium Touch becomes a best-seller in the beauty category on AmazonBest hair mask for dry locks: Shiseido FINO Premium Touch becomes a best-seller in the beauty category on Amazon
7news.com.au - March 24 at 11:07 PM
Cosmetics maker Shiseido Group emphasizes commitment to ChinaCosmetics maker Shiseido Group emphasizes commitment to China
chinadaily.com.cn - March 24 at 8:48 AM
Shiseido Again Defeats Suit Over PFAS in bareMinerals ProductsShiseido Again Defeats Suit Over PFAS in bareMinerals Products
news.bloomberglaw.com - March 20 at 8:55 PM
Shiseido: Business Restructuring Plan In The SpotlightShiseido: Business Restructuring Plan In The Spotlight
seekingalpha.com - March 18 at 9:28 AM
Cheaper anti-wrinkle eye cream brands outperform Sulwhasoo, Estee Lauder and Shiseido, Hong Kong watchdog findsCheaper anti-wrinkle eye cream brands outperform Sulwhasoo, Estee Lauder and Shiseido, Hong Kong watchdog finds
msn.com - March 15 at 1:45 PM
Shiseido promotes Alberto Noé to President and CEO EMEAShiseido promotes Alberto Noé to President and CEO EMEA
cosmeticsbusiness.com - March 15 at 1:45 PM
Cheaper anti-wrinkle eye cream brands outperform Sulwhasoo, Estee Lauder, Shiseido, Hong Kong watchdog findsCheaper anti-wrinkle eye cream brands outperform Sulwhasoo, Estee Lauder, Shiseido, Hong Kong watchdog finds
msn.com - March 14 at 7:42 PM
Elevating Beauty: Nicole Tans Vision for Shiseido Asia PacificElevating Beauty: Nicole Tan's Vision for Shiseido Asia Pacific
bangkokpost.com - March 13 at 9:25 AM
Shiseido gets grant for fluid product dispenser with angular indexing mechanism for fasteningShiseido gets grant for fluid product dispenser with angular indexing mechanism for fastening
just-drinks.com - March 4 at 8:39 AM
Shiseido offers early retirement to 1,500 staff as part of ‘transformation plan’Shiseido offers early retirement to 1,500 staff as part of ‘transformation plan’
cosmeticsbusiness.com - March 1 at 11:50 AM
Shiseido offers early retirement for 1,500 employees in JapanShiseido offers early retirement for 1,500 employees in Japan
www3.nhk.or.jp - March 1 at 6:49 AM
Shiseido Offers Early Retirement to 1,500 Employees in JapanShiseido Offers Early Retirement to 1,500 Employees in Japan
uk.movies.yahoo.com - February 29 at 7:31 AM
India Attractive Beauty Mkt for L’Oréal, ShiseidoIndia Attractive Beauty Mkt for L’Oréal, Shiseido
economictimes.indiatimes.com - February 14 at 5:55 PM
Shiseido 2023 profits crash as China slowdown hits salesShiseido 2023 profits crash as China slowdown hits sales
cosmeticsbusiness.com - February 12 at 1:03 PM
Shiseido Earnings Hit by ChinaShiseido Earnings Hit by China
globalcosmeticsnews.com - February 12 at 1:38 AM
Heres what to expect from Shiseidos earningsHere's what to expect from Shiseido's earnings
markets.businessinsider.com - February 9 at 10:15 AM
Shiseido America Completes Dr. Dennis Gross Skincare AcquisitionShiseido America Completes Dr. Dennis Gross Skincare Acquisition
beautypackaging.com - February 7 at 1:02 PM
Shiseido Americas Completes Acquisition of Dr. Dennis Gross SkincareShiseido Americas Completes Acquisition of Dr. Dennis Gross Skincare
finance.yahoo.com - February 6 at 8:11 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Astellas Pharma logo

Astellas Pharma

OTCMKTS:ALPMY
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.
CSL logo

CSL

OTCMKTS:CSLLY
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals

NASDAQ:REGN
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Shiseido logo

Shiseido

OTCMKTS:SSDOY
Shiseido Company, Limited engages in the production and sale of cosmetics in Japan and internationally. The company offers fragrances; and skincare and makeup products. It also engages in the restaurant and food, and retail businesses; and operates beauty salons. In addition, the company operates and supports SABFA, a professional hair makeup training school. Further, it offers childcare facilities. The company sells its products through department, specialized cosmetic, drug, and general merchandise stores. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.